Literature DB >> 33671532

MR-Imaging and Histopathological Diagnostic Work-Up of Patients with Spontaneous Lobar Intracerebral Hemorrhage: Results of an Institutional Prospective Registry Study.

Patrick Schuss1, Christian Bode2, Valeri Borger1, Christoph Coch3, Ági Güresir1, Alexis Hadjiathanasiou1, Motaz Hamed1, Klaus Kuchelmeister4, Felix Lehmann2, Marcus Müller5, Matthias Schneider1, László Solymosi6, Hartmut Vatter1, Markus Velten2, Erdem Güresir1.   

Abstract

Intracerebral hemorrhage (ICH) is a frequently disabling or fatal disease. The localization of ICH often allows an etiological association. However, in atypical/lobar ICH, the cause of bleeding is less obvious. Therefore, we present prospective histopathological and radiological studies which were conducted within the diagnostic workup to identify causes for lobar ICH other than hypertension. From 2016 to 2018, 198 patients with spontaneous, non-traumatic ICH requiring neurosurgical monitoring were enrolled in an institutional prospective patient registry. Patients with deep-seated ICH and/or hemorrhagically transformed cerebral infarcts were excluded from further analysis. Data to evaluate the source of bleeding based on histopathological and/or radiological workup were prospectively evaluated and analyzed. After applying the inclusion criteria and excluding patients with incomplete diagnostic workup, a total of 52 consecutive patients with lobar ICH were further analyzed. Macrovascular disease was detected in 14 patients with lobar ICH (27%). In 11 patients, diagnostic workup identified cerebral amyloid angiopathy-related ICH (21%). In addition, five patients with tumor-related ICH (10%) and six patients with ICH based on infectious pathologies (11%) were identified. In four patients, the cause of bleeding remained unknown despite extensive diagnostic workup (8%). The present prospective registry study demonstrates a higher probability to identify a cause of bleeding other than hypertension in patients with lobar ICH. Therefore, a thorough diagnostic work-up in patients with ICH is essential to accelerate treatment and further improve outcome or prevent rebleeding.

Entities:  

Keywords:  AVM; CAA; diagnostic work-up; etiology; intracerebral hemorrhage; tumor

Year:  2021        PMID: 33671532     DOI: 10.3390/diagnostics11020368

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  4 in total

1.  Treatment-Limiting Decisions in Patients with Spontaneous Intracerebral Hemorrhage.

Authors:  Felix Lehmann; Matthias Schneider; Joshua D Bernstock; Christian Bode; Valeri Borger; Stefan Felix Ehrentraut; Florian Gessler; Anna-Laura Potthoff; Christian Putensen; Lorena M Schenk; Julian Zimmermann; Hartmut Vatter; Patrick Schuss; Alexis Hadjiathanasiou
Journal:  Medicina (Kaunas)       Date:  2022-07-25       Impact factor: 2.948

2.  CT and DSA for evaluation of spontaneous intracerebral lobar bleedings.

Authors:  Jens-Christian Altenbernd; Sebastian Fischer; Wolfram Scharbrodt; Sebastian Schimrigk; Jens Eyding; Hannes Nordmeyer; Christine Wohlert; Nils Dörner; Yan Li; Karsten Wrede; Daniela Pierscianek; Martin Köhrmann; Benedikt Frank; Michael Forsting; Cornelius Deuschl
Journal:  Front Neurol       Date:  2022-10-03       Impact factor: 4.086

3.  Predictive Relevance of Baseline Lactate and Glucose Levels in Patients with Spontaneous Deep-Seated Intracerebral Hemorrhage.

Authors:  Felix Lehmann; Lorena M Schenk; Matthias Schneider; Joshua D Bernstock; Christian Bode; Valeri Borger; Florian Gessler; Erdem Güresir; Alexis Hadjiathanasiou; Motaz Hamed; Marcus Müller; Christian Putensen; Julian Zimmermann; Hartmut Vatter; Patrick Schuss
Journal:  Brain Sci       Date:  2021-05-14

4.  Admission Dehydration Status Portends Adverse Short-Term Mortality in Patients with Spontaneous Intracerebral Hemorrhage.

Authors:  Felix Lehmann; Lorena M Schenk; Joshua D Bernstock; Christian Bode; Valeri Borger; Florian Gessler; Erdem Güresir; Motaz Hamed; Anna-Laura Potthoff; Christian Putensen; Matthias Schneider; Julian Zimmermann; Hartmut Vatter; Patrick Schuss; Alexis Hadjiathanasiou
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.